The estimated Net Worth of Michael John Sumner is at least $53.8 Tysiąc dollars as of 30 June 2024. Michael Sumner owns over 2,917 units of Inovio Pharmaceuticals Inc stock worth over $53,834 and over the last 2 years Michael sold INO stock worth over $0.
Michael has made over 3 trades of the Inovio Pharmaceuticals Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Michael exercised 2,917 units of INO stock worth $19,106 on 30 June 2024.
The largest trade Michael's ever made was exercising 35,000 units of Inovio Pharmaceuticals Inc stock on 30 June 2023 worth over $229,250. On average, Michael trades about 5,758 units every 52 days since 2022. As of 30 June 2024 Michael still owns at least 8,219 units of Inovio Pharmaceuticals Inc stock.
You can see the complete history of Michael Sumner stock trades at the bottom of the page.
Michael's mailing address filed with the SEC is 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462.
Over the last 19 years, insiders at Inovio Pharmaceuticals Inc have traded over $23,656,819 worth of Inovio Pharmaceuticals Inc stock and bought 1,958,377 units worth $5,174,071 . The most active insiders traders include Austin W & Greenhouse David..., Jong Joseph Kim oraz Felix Theeuwes. On average, Inovio Pharmaceuticals Inc executives and independent directors trade stock every 22 days with the average trade being worth of $745,390. The most recent stock trade was executed by Michael John Sumner on 30 June 2024, trading 2,917 units of INO stock currently worth $19,106.
inovio is revolutionizing the fight against cancer and infectious diseases. our immunotherapies uniquely activate best-in-class immune responses to prevent and treat disease, and have shown clinically significant efficacy with a favorable safety profile. with an expanding portfolio of immune therapies, the company is advancing a growing preclinical and clinical stage product pipeline. partners and collaborators include roche, medimmune, university of pennsylvania, darpa, drexel university, nih, hiv vaccines trial network, national cancer institute, u.s. military hiv research program, and university of manitoba. for more information, visit www.inovio.com.
Inovio Pharmaceuticals Inc executives and other stock owners filed with the SEC include: